Best known globally for its aspirin and locally for its life-saving hemophilia treatments, drug giant Bayer is firming up plans to lead one of biotech's hottest areas with a pioneering new cell therapy manufacturing facility on its fast-changing Berkeley campus.
The moves come as Bayer seeks approval from Berkeley leaders for a new 30-year master plan that would allow the Germany-based company to build 1 million square feet of production, research and office space and add some 1,000 employees over that period.
At the forefront of Bayer's big plans are cell therapies, which employ genetically engineered cells to fix blood cancers and potentially more diseases, and one-shot-and-done gene therapies that insert a correct copy of a gene to replace a defective, disease-causing gene.
By Osagie K. Obasogie, L.A. Review of Books | 04.17.2024
Aggregated News
When Robert G. Edwards won the Nobel Prize in Physiology or Medicine in 2010 for developing in vitro fertilization (IVF) decades earlier in 1978, many members of the scientific community sighed in relief. This honor, they felt, was long...
“It hurt,” my friend told me. “They don’t tell you that it hurts.”
Her voice came heavy through my headphones as I scrubbed the dinner dishes. “Like, I could feel the needle going through all the layers—skin, fat, muscle—and I could...
Amy Yin always envisioned having at least two daughters. She spent her 20s working as an engineer and founding a startup in San Francisco. When she wasn’t working, vacationing with friends, and spoiling her cats, Amy dedicated herself to...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
Aggregated News
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
The Center for Genetics and Society is fiscally sponsored by Tides Center, a 501(c)(3) non-profit organization.
Please visit www.tides.org/state-nonprofit-disclosures for additional information.